Center, an ultra-high-performance brain-dedicated scanner called the NeuroEXPLORER (NX) is redefining what is possible in ...
LECOM Health Corry Memorial Hospital (CMH) has successfully launched a Positron Emission Tomography and Computed Tomography ...
RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in ...
Morning Overview on MSN
Routine brain scans may hide an early Alzheimer’s warning
Routine brain scans are starting to reveal something that was invisible to doctors a decade ago: subtle structural changes ...
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to interim results. To date, 11 of the 12 ...
Radiopharm Theranostics shares rise after interim Phase 2b data showed 92% MRI concordance for RAD 101 imaging in brain metastases.
News-Medical.Net on MSN
New framework tracks response to anti-amyloid therapies in Alzheimer's
In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...
Introduced brain-imaging analysis products, including Neurophet AQUA AD, which enables monitoring of adverse effects related ...
Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to ...
A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.
The authoritative neuroradiology reference Diagnostic Imaging: Brain, Fifth Edition (Elsevier) now confirms that functional ...
New research shows that deep learning can use EEG signals to distinguish Alzheimer’s disease from frontotemporal dementia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results